Progressive adverse effects on the reproductive and hematopoietic systems and progressive telomere shortening are observed in successive generations of breeding of mice that are homozygous null for the Terc gene . Germ cells exhibit decreased rates in proliferation and increased rates of apoptosis resulting in a general state of germ cell depletion; fertility is significantly diminished. Proliferative capacity of hematopoietic cells derived from bone marrow and spleen is significantly compromised.
Dr. Carol Greider, Johns Hopkins Univ School of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Terc | telomerase RNA component |
Early generation mice that are homozygous null for the Terc gene are phenotypically normal. No Terc transcript or telomerase activity is detected. If null mice are maintained as homozygotes, progressive adverse effects on the reproductive and hematopoietic systems are observed. By the fifth generation of homozygous intercrossing, fertility is significantly diminished. Testes size and weight is reduced by ~80%. Germ cells exhibit decreased rates in proliferation and increased rates of apoptosis resulting in a general state of germ cell depletion. Females exhibit smaller ovaries and diminished uterine horns. The proliferative capacity of hematopoietic cells derived from bone marrow and spleen is significantly compromised. Progressive generations of interbreeding the null mice results in progressive telomere shortening (4.8 +/- 2.4 kb per generation). Cells from the fourth generation onward possess chromosome ends lacking detectable telomere repeats, aneuploidy, and chromosomal abnormalities, including end-to-end fusions.
In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. It should be noted that the phenotype of these DBA/2J-congenic mice could vary from that originally described on a B6J genetic background. We may modify the strain description if necessary as published results become available.
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt the entire Terc gene. The construct was electroporated into WW6 embryonic stem (ES) cells. WW6 ES cells are derived from a mixed genetic background (C57BL/6J ,129/Sv and SJL). Correctly targeted ES cells were injected into C57BL/6J blastocysts. The resulting chimeric animals were backcrossed to C57BL/6J mice. This strain was backcrossed to C57BL/6J (Stock No. 000664) for at least seven generations. These mice arrived at The Jackson Laboratory Repository as Stock No. 004132. Some mice were bred to DBA/2J inbred mice (Stock No. 000671) for many generations using a marker-assisted, speed congenic approach to generate this DBA/2J-congenic strain (Stock No. 022527).
Allele Name | targeted mutation 1, Ronald DePinho |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | mTerc-; mTR-; Terc-; TR- |
Gene Symbol and Name | Terc, telomerase RNA component |
Gene Synonym(s) | |
Strain of Origin | STOCK 129/Sv and C57BL/6J and SJL |
Chromosome | 3 |
Molecular Note | Replacement of the entire gene with a neomycin cassette. |
Mutations Made By | Dr. Carol Greider, Johns Hopkins Univ School of Medicine |
Mutant mice were bred to DBA/2J inbred mice (Stock No. 000671) for several generations using a marker-assisted, speed congenic approach to establish this congenic strain. When maintaining the live congenic colony, heterozygous mice are bred together. The coat color expected from breeding is black.
When using the mTR- mouse strain in a publication, please cite the originating article(s) and include JAX stock #022527 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Terc<tm1Rdp> |
Frozen Mouse Embryo | D2.Cg-Terc<tm1Rdp>/J | $2595.00 |
Frozen Mouse Embryo | D2.Cg-Terc<tm1Rdp>/J | $2595.00 |
Frozen Mouse Embryo | D2.Cg-Terc<tm1Rdp>/J | $3373.50 |
Frozen Mouse Embryo | D2.Cg-Terc<tm1Rdp>/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.